![Michael Jerman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Jerman
Directeur/Membre du Conseil chez
HEDGEPATH PHARMACEUTICALS INC
Fortune : 51 274 $ au 31/05/2026
Profil
Mr. Michael A. Jerman is an Independent Director at Alaunos Therapeutics, Inc., an Independent Director at Inhibitor Therapeutics, Inc. and a Managing Partner at Hollywell Partners LLC.
He is on the Board of Directors at Alaunos Therapeutics, Inc. and Inhibitor Therapeutics, Inc. Mr. Jerman was previously employed as an Independent Director by MIRA Pharmaceuticals, Inc. and an Independent Director by Telomir Pharmaceuticals, Inc. He also served on the board at PricewaterhouseCoopers LLP.
He received his undergraduate degree from the University of South Florida, a graduate degree from The University of Tampa, Inc. and an MBA from the University of Oxford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/04/2026 | 15 621 ( 0,64 % ) | 44 520 $ | 31/05/2026 | |
| 01/04/2025 | 80 411 ( 0,05 % ) | 6 755 $ | 31/05/2026 |
Postes actifs de Michael Jerman
| Sociétés | Poste | Début |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Directeur/Membre du Conseil | 24/05/2023 |
| ALAUNOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/07/2025 |
HOLLYWELL PARTNERS LLC
 HOLLYWELL PARTNERS LLC Miscellaneous Commercial ServicesCommercial Services Operates as a financial company that provides strategy to enhance business growth for organization services | Corporate Officer/Principal | 01/05/2019 |
Anciens postes connus de Michael Jerman
| Sociétés | Poste | Fin |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 18/11/2024 |
| MIRA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 18/11/2024 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Directeur/Membre du Conseil | 01/08/2019 |
Formation de Michael Jerman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Tampa, Inc.
 The University of Tampa, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
HOLLYWELL PARTNERS LLC
HOLLYWELL PARTNERS LLC Miscellaneous Commercial ServicesCommercial Services Operates as a financial company that provides strategy to enhance business growth for organization services | Commercial Services |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
